@FiercePharma: Yesterday's top-read news: Gilead's Sovaldi sales through the roof already, analyst predicts at least $8B this year. Story | Follow @FiercePharma
@TracyStaton: Every Dog Has Its Data: The quantified self for pets, via The New York Times. Article (sub. req.) | Follow @TracyStaton
@EricPFierce: Pfizer's Effexor XR one of a host of recalls lately that include products from Mylan, Baxter and Gilead. More | Follow @EricPFierce
@CarlyHFierce: As promised: BTG recoils at rattlesnake roundup 'gassing.' Item | Follow @CarlyHFierce
> AstraZeneca ($AZN) launched its combination diabetes drugs Xigduo in the U.K. and won a recommendation for health service use of its related drug, Forxiga, in Scotland. Report
> Roche's ($RHHBY) Genentech unit can pursue its patent claims against the generics maker Apotex, a federal judge ruled, allowing a patent fight over the antiviral Valcyte to proceed. Report
> Sanofi ($SNY) won a place on Scotland's National Health Service formulary for its multiple sclerosis pill Aubagio. Report
> A U.S. judge kicked a Plavix marketing case back to West Virginia court, thwarting Bristol-Myers Squibb ($BMY) and Sanofi's ($SNY) attempt to move it to federal court. Report
> U.S. cancer doctors worry that they won't be able to handle a surge in cancer cases at proposed Medicare reimbursement rates, at a time when costs of treatment, including drugs, are rising. Report
> Australia has scrapped its Pharmaceutical Benefits Pricing Authority, which makes pricing recommendations to government officials, as of April 1. Report
@FierceMedDev: Lombard Medical in the U.K. detailed plans for a proposed $80M IPO driven by its aortic repair device. S-1 form | Follow @FierceMedDev
@MarkHFierce: Exosome Diagnostics raised $27M to bring its prostate cancer urine test to market. More | Follow @MarkHFierce
@MichaelGFierce: Nanoparticles breach blood-brain barrier as possible Alzheimer's treatment. Item from FierceDrugDelivery | Follow @MichaelGFierce
@EmilyWFierce: Industry report shows bleak 2013 for med tech industry. Story | Follow @EmilyWFierce
@GalenMoore: Spanish researchers find a protein adults need for brain plasticity could delay the effects of Alzheimer's disease. Abstract | Follow @GalenMoore
> Roche and Bayer expand their companion Dx partnership into multiple projects. Article
> TriVascular envisions a $100M IPO to propel AAA stent graft rollout. News
Biotech News
@FierceBiotech: Kythera buys back Bayer's stake in PhIII chin-fat therapy in $84M deal. News | Follow @FierceBiotech
@JohnCFierce: Commentary--The dying child vs. the biotech: Everybody loses. Editor's Corner | Follow @JohnCFierce
@DamianFierce: Yesteryear's megamergers are, in part, driving Big Pharma's external R&D push, says John LaMattina. Forbes piece | Follow @DamianFierce
@EmilyMFierce: Scientists from Notre Dame ID new class of antibiotics to combat MRSA. Story | Follow @EmilyMFierce
> Lumena banks $45M and hits the gas on two liver treatments. More
> Novartis's new Basel campus reflects Vasella's (now out-of-fashion) style. Article
Biotech Research News
> University of Notre Dame team IDs new class of antibiotics. Article
> Stem cell therapy improves Parkinson's symptoms in monkeys. Story
> NIH faces flat funds in president's 2015 budget proposal. News
> Seattle BioMed receives $10M NIAID grant to lead AIDS vaccine effort. News
> Antipsychotic drugs may have another use: Treating deadly brain tumors. Story
> OHSU opens new stem cell research center. Brief
Pharma Manufacturing News
> BMS joins Merck with plans to whack plants in Ireland. News
> Global rise in pain drug use puts the hurt on Tasmania's poppy production. Story
> Source: Ranbaxy shops for Nexium API to salvage lucrative launch. Article
> Ranbaxy recalls generic Lipitor after druggist finds 20-mg dose in 10-mg bottle. News
> Pfizer recalls bottles of antidepressant that might have a heart drug mixed in. Story
> Pfizer is expanding its plant in Indonesia--again. Brief
And Finally... The state of Colorado brought in about $2 million in extra tax revenue during the first month of recreational marijuana sales there. Report